LATTUADA, Emanuela
 Distribuzione geografica
Continente #
EU - Europa 1.545
NA - Nord America 1.480
AS - Asia 996
SA - Sud America 184
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.223
Nazione #
US - Stati Uniti d'America 1.444
RU - Federazione Russa 626
SG - Singapore 393
CN - Cina 360
GB - Regno Unito 294
BR - Brasile 159
SE - Svezia 114
DE - Germania 98
IE - Irlanda 92
HK - Hong Kong 84
FR - Francia 83
IT - Italia 81
FI - Finlandia 74
VN - Vietnam 65
UA - Ucraina 24
KR - Corea 23
CA - Canada 21
CZ - Repubblica Ceca 16
JP - Giappone 14
IN - India 13
MX - Messico 13
TR - Turchia 13
AR - Argentina 11
ZA - Sudafrica 11
BE - Belgio 9
PL - Polonia 9
ID - Indonesia 6
NL - Olanda 6
AT - Austria 5
BD - Bangladesh 5
IQ - Iraq 5
CL - Cile 4
LT - Lituania 4
ES - Italia 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
MA - Marocco 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
MN - Mongolia 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 4.223
Città #
Southend 246
Chandler 235
Moscow 215
Singapore 178
Jacksonville 152
Woodbridge 127
Ashburn 105
Dublin 91
Dallas 87
Hong Kong 84
Beijing 74
Ann Arbor 70
Houston 40
New York 38
Los Angeles 36
Lawrence 33
Princeton 33
Jinan 32
Wilmington 29
Munich 28
Shenyang 27
Helsinki 26
Nanjing 23
Ho Chi Minh City 21
Brno 15
Hebei 15
Denver 14
Redondo Beach 13
Santa Clara 13
Tokyo 13
Turku 13
Hanoi 12
Buffalo 11
Nanchang 11
Ningbo 11
São Paulo 11
Toronto 11
Verona 11
San Francisco 10
Seoul 10
Tianjin 10
Atlanta 9
Boardman 9
Brussels 9
Changsha 9
Warsaw 9
Bologna 8
Haikou 8
Hangzhou 8
Johannesburg 8
Orem 8
Redmond 8
Sindelfingen 8
The Dalles 8
Boston 7
Frankfurt am Main 7
Jiaxing 7
Lanzhou 7
London 7
Phoenix 7
Rio de Janeiro 7
Zhengzhou 7
Chennai 6
Clearwater 6
Guangzhou 6
Milan 6
Montreal 6
Norwalk 6
Taizhou 6
Brooklyn 5
Dong Ket 5
Pignone 5
Stockholm 5
Belo Horizonte 4
Bursa 4
Chicago 4
Council Bluffs 4
Manchester 4
Poplar 4
Querétaro 4
Scandiano 4
Seattle 4
Taiyuan 4
Vicenza 4
Amsterdam 3
Caxias do Sul 3
Columbus 3
Düsseldorf 3
Fairfield 3
Falls Church 3
Fuzhou 3
Giussano 3
Haiphong 3
Jakarta 3
Limeira 3
Mexico City 3
Monterrey 3
Mumbai 3
Nuremberg 3
Redwood City 3
Totale 2.553
Nome #
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 169
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 159
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 156
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 156
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 150
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 149
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 148
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 148
No improvement of lipodystrophy syndrome in an HIV-infected patient. 143
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 143
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 141
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 139
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 134
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 134
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 133
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 133
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 133
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 133
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 132
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 124
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 119
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 115
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 115
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 114
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 111
Raltegravir: is a 400 mg once-daily dose enough? 108
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 106
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 106
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 101
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 98
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 96
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 93
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 79
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 68
Totale 4.286
Categoria #
all - tutte 15.121
article - articoli 15.121
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 39 26 7 22 16 13 24 11
2021/2022303 29 107 1 25 2 3 3 19 15 11 16 72
2022/2023620 36 85 50 94 62 154 0 39 77 2 10 11
2023/2024287 16 26 30 21 36 48 2 17 3 14 40 34
2024/2025673 37 41 15 97 38 13 37 18 112 46 62 157
2025/20261.356 146 112 119 425 554 0 0 0 0 0 0 0
Totale 4.286